猪源脑心肌炎病毒单克隆抗体研制与免疫学特性测定

利用纯化灭活的猪源脑心肌炎病毒(EMCV)免疫BALB/c小鼠,采用杂交瘤细胞技术,研制获得4株能稳定分泌抗EMCV抗体的杂交瘤细胞株,分别命名为1D1、2A2、2B6和4E2。经ELISA测定,细胞培养上清中抗体效价分别为1∶1 600,1∶6 400,1∶6 400和1∶3 200,小鼠腹水抗体效价分别为1∶1.63×106,1∶3.28×106,1∶1.13×106和1∶5.63×105。1D1和2A2单抗亚类为IgG1,2B6和4E2单抗亚类为IgG2b,轻链均为κ型。Western blot结果表明,1D1、2A2和4E2能特异性识别病毒的VP1蛋白,2B6能特异性识别病毒的VP2蛋白。间接免疫荧光试验证明,4株单抗具有良好的特异性,均能识别EMCV。本研究获得的4株特异性单抗,将为EMCV诊断方法的建立和病毒蛋白功能的研究奠定基础。     

抗猪戊型肝炎病毒重组蛋白单克隆抗体的制备和鉴定

利用纯化的猪戊型肝炎病毒(HEV)ORF2-M1重组蛋白免疫Balb/c小鼠,采用杂交瘤细胞技术,获得了2株稳定分泌抗HEV ORF2-M1重组蛋白单克隆抗体的杂交瘤细胞株,分别命名为BC4和2A10。经ELISA测定,2株杂交瘤细胞培养上清效价分别为1∶1.60×103和1∶0.80×103,接种小鼠的腹水效价分别为1∶2.56×106和1∶1.28×106。2株单抗均能特异性识别重组ORF2-M1蛋白,但它们识别ORF2-M1蛋白的不同表位。间接免疫荧光试验证实,2株单抗具有良好的特异性,均能够识别HEV。     

猪细小病毒核衣壳VP2蛋白单克隆抗体的制备及部分特性鉴定

以纯化的PPV重组VP2蛋白免疫BALB/c小鼠,通过细胞融合技术,间接ELISA筛选和3次以上细胞克隆,获得了5株稳定分泌抗PPV VP2蛋白单克隆抗体杂交瘤细胞株,分别命名为2D5、1F11、2B4、3C8、1 H3。其染色体平均数均为87～102条,分泌抗体亚类4株为Ig M类,1株为IgG类,Western blot检测表明,5株单抗均识别猪细小病毒VP2蛋白;间接免疫荧光鉴定表明,5株单抗均与PPV全病毒发生反应;间接ELISA鉴定与其他相关病毒的交叉反应性表明,制备的5株单抗不与TEGV、PRV和PEDV反应,表明所制备的抗体与猪细小病毒具有较强的特异性反应。     

流产嗜性衣原体MIP蛋白单克隆抗体的制备及特性鉴定

为制备抗流产嗜性衣原体MIP蛋白单克隆抗体,以纯化的重组MIP蛋白为抗原,免疫Balb/c小鼠后经细胞融合,间接ELISA法筛选阳性细胞克隆并进行有限稀释克隆化,建立了两株分泌抗MIP蛋白单克隆抗体的杂交瘤细胞株,将其分别命名为M1,M2。间接ELISA测杂交瘤细胞上清抗体效价为1∶1600、相对亲和力为10μg/m L;Western blot鉴定两株单克隆抗体能特异识别MIP重组蛋白;细胞核型实验鉴定单抗符合杂交瘤细胞的特性;单克隆抗体亚类检测试剂盒鉴定两株单抗免疫球蛋白类型均为Ig G1,轻链为κ链;体外中和试验表明,两株单抗均能有效阻断感染。抗MIP单克隆抗体的成功制备将为建立诊断、治疗方法及MIP蛋白的进一步研究奠定基础。     

鸭1型甲肝病毒亚型VP1蛋白单克隆抗体的研制及鉴定

为制备抗鸭1型甲肝病毒亚型（DHAV-1a）结构蛋白VP1的单克隆抗体（MAbs）,本研究以pGEX-VP1重组蛋白免疫BALB/c小鼠,同时以纯化浓缩的全病毒作为包被抗原,建立了筛选抗VP1蛋白阳性杂交瘤细胞株的间接ELISA方法,经融合、筛选制备杂交瘤细胞及鉴定MAbs的稳定性、特异性、腹水效价和中和活性等生物学活性,获得了2株持续且稳定分泌抗体的杂交瘤细胞（1A2和5G3）。MAbs腹水ELISA效价分别为1：3.2×10⁴和1：2.0×10⁶。亚类鉴定均为IgG1/κ型。Western blotting结果显示,2株MAbs均能与DHAV-1a VP1蛋白和DHAV-1a全病毒发生特异性反应。特异性试验结果显示2株MAbs能与鸭1型甲肝病毒（DHAV-1）和DHAV-1a发生交叉反应。中和试验结果显示5G3株具有中和活性。结果表明2株MAbs的ELISA效价高、特异性强、稳定性好,均能与DHAV-1和DHAV-1a全病毒发生特异性反应,其中一株具有中和活性。     

猪圆环病毒2型ORF2重组蛋白单克隆抗体的制备及鉴定

利用已构建的基因工程重组菌BL21(DE3)表达猪圆环病毒2型(PCV2)ORF2编码的结构蛋白,经切胶纯化后作为免疫原。采取抗原量依次递增的免疫方式免疫8周龄BALB/c小鼠,取其脾细胞与Sp2/0骨髓瘤细胞融合。间接酶联免疫吸附试验(ELISA)筛选,有限稀释法进行亚克隆3次,最终获得4株稳定分泌抗PCV2 ORF2重组蛋白单克隆抗体的杂交瘤细胞,分别命名为D2A1、H4G2、B10H10和G1G2。经ELISA检测,其腹水效价分别达到1∶2.048×107、1∶2.56×106、1∶1.28×106、1∶2.56×106。亚型鉴定4株单克隆抗体均属IgG2a亚型,其轻链均为κ链。Western blot鉴定表明获得的4株单克隆抗体均能特异性的识别43 kD的重组PCV2 ORF2蛋白。在间接免疫荧光试验中,单抗D2A1株的反应为阴性,H4G2、B10H10和G1G2反应为阳性,表明后3株单抗能够识别天然的PCV2 ORF2蛋白表位。本试验为进一步研究PCV2ORF2基因的功能及建立快速准确的诊断PCV2的方法奠定了基础。     

O型口蹄疫泛亚毒株单克隆抗体的制备及抗原表位差异分析

用纯化的O型口蹄疫泛亚毒株免疫BALB/c小鼠,取免疫小鼠脾细胞与SP 2/0骨髓瘤细胞进行融合,经3次克隆和间接EL ISA筛选,获得了ⅢA 11、ⅢC 3和ⅢF 10 3株稳定分泌单克隆抗体的杂交瘤细胞株。通过间接EL ISA测定,单抗效价为:细胞培养上清1∶160~1∶640,腹水为1∶5×104~1∶4×105;经EL ISA法测定,3株单克隆抗体均与泛亚株VP 1蛋白反应,而不与A型口蹄疫病毒VP 1蛋白反应;单抗的亚类鉴定结果表明,ⅢA 11和ⅢF 10分泌的抗体为IgG 1亚类,ⅢC 3分泌的抗体为IgG 2b亚类。单克隆抗体抗原识别位点分析结果表明,ⅢA 11与另外2种单克隆抗体的识别位点不同,而ⅢC 3和ⅢF 10的识别位点相近。     

传染性囊病病毒(IBDV)VP3蛋白单克隆抗体的制备与鉴定

为制备抗IBDV VP3蛋白的单克隆抗体,以VP3-His蛋白免疫BALB/c小鼠,经4次免疫、融合、亚克隆,筛选出1株能够稳定分泌抗VP3蛋白单克隆抗体的细胞株,命名为4H8F7C10。经间接ELISA方法检测,小鼠的腹水效价为2.05×106,单克隆抗体的解离常数(k D)为9.67×10-8,此株抗体亚类为Ig G3。通过Western Blot和间接免疫荧光试验检测,该株单克隆抗体可以识别IBDV感染DF-1细胞产生的VP3蛋白。初步确定此株单克隆抗体的抗原识别区位于VP3蛋白N端的第50-90位氨基酸。此株单克隆抗体的制备为IBDV临床检测方法的建立以及致病分子机制的研究奠定了基础。     

传染性囊病病毒VP5蛋白单克隆抗体的制备及鉴定

传染性囊病病毒(Infectious Bursal Disease Virus,IBDV)的非结构蛋白VP5在病毒感染细胞的不同阶段发挥着抑制或诱导细胞凋亡的重要作用。为制备抗血清I型IBDV VP5蛋白的单克隆抗体,取经His-VP5蛋白免疫4次的BALB/c小鼠的脾细胞与骨髓瘤细胞(SP2/0)进行融合,3次亚克隆后获得2株能稳定分泌VP5蛋白单克隆抗体的杂交瘤细胞株,分别命名为5EC7和2BE5。经间接ELISA测定,以上2株单抗的亲和力解离常数分别为1.14×10~(-10)和4.87×10~(-10),亚类分别为Ig G2a和Ig G1。通过Western Blot和间接免疫荧光试验检测,2株单抗均能识别IBDV感染DF-1细胞后产生的VP5蛋白。Western Blot试验表明,2株单抗识别的抗原表位区域为VP5 N-端的1~10 aa。该单抗为研究血清I型IBDV VP5蛋白的生物学功能及病毒致病机理奠定基础。     

抗酵母表达犬细小病毒蛋白VP2的单克隆抗体的制备和鉴定

以纯化的酵母重组表达的犬细小病毒VP2单位免疫BALB／C小鼠,采用B淋巴细胞杂交瘤技术,通过ELISA方法筛选,获得4株能稳定分泌抗犬细小病毒CPV结构蛋白VP2的单克隆抗体杂交瘤细胞株。4株单克隆抗体中,2株属于IgG2b亚类,2株属于IgG1亚类,其腹水效价可达到1：51200和1：204800,细胞培养上清液效价可达1：256、1：512。ELISA分析表明,这些单抗仅与CPV及其VP2发生特异性反应,而与CDV和CAV-1及CAV-2没有交叉反应;荧光免疫染色病毒检测进一步表明单克隆抗体的特异性效果好。这些特异性单抗的制备为建立有效的检测犬细小病毒感染奠定了基础。     

H9亚型禽流感病毒基质蛋白M1单克隆抗体的制备与鉴定

本研究用纯化的H9N2亚型禽流感病毒免疫BALB/c小鼠,取其脾细胞与SP2/0骨髓瘤细胞融合。对杂交瘤细胞及时筛选,阳性孔经3次有限稀释法克隆,成功获得3株能稳定传代并分泌抗H9亚型禽流感病毒基质蛋白M1单克隆抗体的杂交瘤细胞：3G8、2F6、5F2。间接ELISA方法检测,3株单克隆抗体的腹水间接ELISA效价达106以上。构建了真核表达载体pCAGGS-M1并转染于MDCK细胞,以用于腹水的Western blot和间接免疫荧光鉴定。间接免疫荧光结果表明,3株单克隆抗体皆与真核表达蛋白M1反应。这些单克隆抗体的制备为后期研究M1蛋白在流感病毒复制与出芽过程中的重要生物学功能奠定了基础。     

鸡传染性贫血病毒VP3蛋白的原核表达及其单克隆抗体的研制

本研究首先利用同源重组一步克隆法将鸡传染性贫血病病毒(CIAV)的VP3基因克隆到pGEX-6P-1原核表达载体上,经IPTG诱导及SDS-PAGE分析成功获得了重组蛋白rGST-VP3的表达.随即以纯化的重组蛋白rGST-VP3免疫Balb/c小鼠,通过脾细胞与SP2/0细胞融合以及间接免疫荧光(IFA)筛选,获得2株稳定分泌CIAV-VP3抗体的杂交瘤细胞株,分别命名为CIAV-VP3-4D7和CIAV-VP3-4G8;亚型鉴定表明,CIAV-VP3-4D7和CIAV-VP3-4G8均为IgG1;效价测定发现,CIAV-VP3-4D7和CIAV-VP3-4G8的腹水间接免疫荧光效价分别为1:102400与1:12800;Western blot进一步证实,CIAV-VP3-4D7和CIAV-VP3-4G8均能识别重组蛋白rGST-VP3.本研究结果为后期研究VP3蛋白在CIAV致病中作用及其诱导凋亡分子机制奠定了坚实的物质基础.     

Development and Identification of Monoclonal Antibodies against VP1 Protein of DHAV-1a

To prepare the monoclonal antibodies (MAbs) against DHAV-1a, hybridomas were produced by fusing SP2/0 cells with spleen cells from mouse immunized with DHAV-1a pGEX-VP1 recombinant protein. Two hybridomas stablely secreting MAbs against VP1 protein were identified by indirect ELISA detection with DHAV-1a as coating antigen. The ascetic fluids of MAbs were 1:3.2×10⁴ and 1:2.0×10⁶, respectively. The MAbs were IgG1 with κ chain. Western blotting analysis showed that the MAbs could recognize the recombinant VP1 protein and DHAV-1a. The neutralization tests showed that one MAb (5G3) had better neutralization activity. Therefore, the results showed that the ELISA titers and specialities of two MAbs were very good, with excellent stability. In addition, they all had cross interaction with DHAV-1 and DHAV-1a, one of which had good neutralization activity.     

Production and characterization of monoclonal antibodies against an avian group A rotavirus.

Fifteen monoclonal antibodies (MAbs) against an avian group A rotavirus were cloned and characterized. Eight of the 15 MAbs had neutralizing activity (N-MAbs). Five of the N-MAbs (1G1, 5B8, 4E2, 3G1, 2E3) were VP4-specific by radioimmunoprecipitation assay (RIPA), and two N-MAbs (2D11, 6E8) were possibly VP7-specific (faint bands by RIPA). One N-MAb (4H12) of undefined protein specificity cross-reacted with serotype 3 simian rotaviruses. The other seven N-MAbs did not cross-react with any of the eight distinct serotypes of human and mammalian rotaviruses tested. Of the seven non-neutralizing MAbs, three were VP6-specific (3H10, 4B12, 5F6), two were VP8-specific (6C9, 1D1), one was VP4-specific (4E9), and one was of undefined protein specificity (1B11). Four non-neutralizing MAbs recognized only avian group A rotavirus in cell-culture immunofluorescence tests (6C9, 1D1, 4E9 and 5F6), whereas two MAbs (3H10 and 4B12) cross-reacted with all human and animal rotaviruses tested. The MAb 1B11 did not recognize any human rotavirus serotypes but cross-reacted with all nonhuman animal rotavirus serotypes. The MAbs produced in this study should be useful for the detection and further characterization of avian group A rotaviruses.     

Production and characterization of monoclonal antibodies to budgerigar fledgling disease virus major capsid protein VP.

Eleven hybridoma cell lines producing monoclonal antibodies (MAbs) against intact budgerigar fledgling disease (BFD) virions were produced and characterized. These antibodies were selected for their ability to react with BFD virions in an enzyme-linked immunosorbent assay. Each of these antibodies was reactive in the immunofluorescent detection of BFD virus-infected cells. These antibodies immunoprecipitated intact virions and specifically recognized the major capsid protein, VP1, of the dissociated virion. The MAbs were found to preferentially recognize native BFD virus capsid protein when compared with denatured virus protein. These MAbs were capable of detecting BFD virus protein in chicken embryonated cell-culture lysates by dot-blot analysis.     

Characterization of proteins of chicken infectious anemia virus with monoclonal antibodies.

Eight monoclonal antibodies (MAbs) against chicken infectious anemia virus (CIAV) were developed. These MAbs identified three isolates adapted to grow in the Marek's disease chicken cell line MSB1 (Cux-1, GA-1, and Conn-B) and the chicken-propagated CIA-1 isolate. All MAbs stained MSB1 in the same way with mostly perinuclear staining, although larger nuclear inclusions and cytoplasmic staining were also detected. None of the MAbs neutralized Cux-1. All MAbs reacted in a direct enzyme-linked immunosorbent assay with Cux-1 antigen treated with 0.5% sodium dodecyl sulfate followed by extraction with chloroform, but not with MSB1 cells infected with Cux-1 or chloroform-extracts of these cells. Three viral proteins--VP1, VP2, and VP3--with estimated sizes of 45, 30, and 16 kilodaltons (kd), respectively, were immunoprecipitated using the MAbs and Cux-1-infected cell lysates. The 16-kd protein was the major VP. In addition, a 79-kd protein was detected in infected cell lysates by immunoprecipitation with CIAV-antibody-positive and -negative chicken serum, and CIAV-specific and non-specific MAbs.     

Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens.

Murine monoclonal antibodies (MAbs) were produced to assist in the identification and characterization of the virus-neutralizing epitopes of infectious bursal disease virus (IBDV). Only MAbs that reacted in Western blotting with viral protein 2 (VP2) or immunoprecipitated VP2 neutralized the infectivity of the virus in cell culture and passively protected young chickens from infection. Three of the neutralizing MAbs did not react with denatured viral proteins. Additivity enzyme-linked immunosorbent assays indicated that the six virus-neutralizing MAbs recognized two spatially independent epitopes. The ability of two of the virus-neutralizing MAbs to neutralize a variant of IBDV that had escaped neutralization by all the other MAbs confirmed the existence of two distinct neutralizing epitopes. The results support the hypothesis that there are at least two non-overlapping epitopes recognized by the virus-neutralizing MAbs reported in this study, although these may still be within one conformational site on VP2 of IBDV.     

H5亚型AIV HA抗原表位重组蛋白McAbs的制备及应用

目的以H5亚型禽流感病毒(avian influenza virus,AIV)的血凝素(HA)抗原表位重组表达蛋白为抗原,探索H5亚型AIV单克隆抗体制备的简便有效途径。方法利用H5亚型AIV的HA抗原表位原核表达重组蛋白为抗原,4次免疫8～10周龄雌性BALB/c小鼠后,取小鼠脾细胞与SP2/0骨髓瘤细胞融合,用间接ELISA方法筛选能分泌单克隆抗体的杂交瘤细胞株,并对单克隆抗体的特性及初步应用价值进行测试。结果得到一株能稳定分泌针对H5亚型AIVHA抗原表位的特异性单克隆抗体杂交瘤细胞株,单克隆抗体ELISA效价达1:5×104,为具有IgK轻链的IgM亚类。该单克隆抗体能特异性地与H5亚型AIV产生肉眼可见的WesternBlot免疫印迹反应,与其它供试的禽病抗原无反应。H5N1亚型AIV阳性血清能有效阻断辣根过氧化酶标记的单克隆抗体与HA抗原表位重组蛋白的结合。结论本研究探索出一条利用H5亚型AIV的HA抗原表位重组表达蛋白为抗原的单克隆抗体制备的简便、高效途径,所制备的单克隆抗体稳定性好、效价高、特异性强,在H5亚型禽流感病毒及其血清学检测中有较高的应用价值。     

Diagnostic methods for African horsesickness virus using monoclonal antibodies to structural and non-structural proteins.

A panel of 32 hybridoma cell lines secreting monoclonal antibodies (MAbs) reactive with African horsesickness virus serotype 4 (AHSV-4) has been developed. Four of the MAbs recognized the major core antigen VP7, twenty recognized the outer capsid protein VP2 and eight reacted with the non-structural protein NS1. With the VP7-specific MAbs a rapid and sensitive double antibody sandwich immunoassay has been developed to detect viral antigen in infected Vero cells and in spleen tissue from AHSV-infected horses. The sensitivity of the assay is 10 ng viral antigen per 100 microliters. The NS1-specific MAbs allowed visualization by immunofluorescence of tubule-like structures in the cytoplasm of infected Vero cells. This can be very useful as a confirmatory diagnostic procedure. The antigenic map of the outer capsid VP2 protein with MAbs is also reported.